Cargando…
Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic
Finding a vaccine that can last a long time and effective against viruses with high mutation rates such as SARS-CoV-2 is still a challenge today. The various vaccines that have been available have decreased in effectiveness and require booster administration. As the professional antigen presenting c...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485669/ https://www.ncbi.nlm.nih.gov/pubmed/36148241 http://dx.doi.org/10.3389/fimmu.2022.989685 |